Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen

2011102 citationsJournal Articlegreen Open Access

Authors

Diana Mansour

Carole Verhoeven · Merck (Netherlands)

Werner Sommer · Merck (Netherlands)

Edith Weisberg · Family Planning NSW

Surasak Taneepanichskul · Chulalongkorn University

Gian Benedetto Melis · University of Cagliari

Inger Sundström Poromaa · Uppsala University

Abstract

These data show that NOMAC/E2 provides high contraceptive efficacy with acceptable cycle control as well as an overall adverse event profile similar to that of DRSP/EE.

Topics & Keywords

Reproductive Health and Contraception Acne and Rosacea Treatments and Effects Pregnancy and Medication Impact

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: The European Journal of Contraception & Reproductive Health Care

Volume 16, Issue 6, pp. 430-443

DOI: 10.3109/13625187.2011.614029

Field-Weighted Citation Impact: 11.30